Shawn Kuhn

@VIPSheffTrades Made a quick ~10% day trade on this one, in at .59 out at .65. Thx Sheff!

@VIPSheffTrades All out as well with a $1.57 average sold price on the day. Crazy indeed.

@LovejoyVapor @VIPSheffTrades Sold 20% of remaining position at $1.70 (had a limit order) set before it collapsed and halted again, thank God. Wild ride.

@VIPSheffTrades T2 and T3 Resumption time 15:00EST….

@VIPSheffTrades I shed half of my position at $1.60 before the halt. Let's see what happens once it resumes! Nice call Sheff.

@Opal_Chip Hello sir, you still in it or adding at these price levels? $GOSS

$GOSS added again today. The more I look at it, the more I think the market is grossly underestimating the chance of FDA allowing a path forward, and sooner rather than later. What's not to like - "The company has engaged with the FDA, advancing from a Type C meeting to a Type B pre-NDA meeting, indicating progress in regulatory discussions." "Pre-NDA". I believe that often comes just before an NDA is filed🤪! Yet market pricing that probability at maybe 10%. Again - read that research summary I posted previously. It's not a slam dunk, but has like 15 cents downside, and say $1.50 upside. 10 to 1.

@Opal_Chip Thanks for the thoughts, mate!

$GUTS mysterious to me (other than knee-jerk technical resistance at $1) why we wouldn't be > $1.25 given this week's data. Approval seems ~80% derisked now and a conservative TAM estimate makes it a $3 stock at that point. Maybe an offering brewing? Not a terrible idea, but also not desperate, so I'd think they'd be looking for solidly above $1. I have enough but will add if I can get .82 area.

@VIPSheffTrades Their cash position is a little suspect with <5 months runway - perhaps they will look to raise after positive catalysts(s)Maybe after the IND accept… and before orphan drug designation? 🤔

@VIPSheffTrades Thanks for these types of valuable insights! Appreciate the effort you put in reaching out to companies.

@VIPSheffTrades $CNTB?

@VIPSheffTrades Sold at $5.40 in the AH today from $4.35 entry. Could t find an AH catalysts, just the pre-market news that FDA approved brand name of QYLEKI. Great call! 🔥🔥🔥

@VIPSheffTrades Out with you both at $8.12 @Opal_Chip

@VIPSheffTrades Dance dance dance 🎇🚀

@Opal_Chip Thanks for your thoughts!

Sorry I didn't see your message until now... Been busy with family stuff and not checking in much. Yes, it looks fine to me. Can't realistically expect much better... I'm likely holding through the early q4 top line data. If that data holds up, there's no reason to believe the trends won't continue indefinitely, with the untreated group weight regain continuing, while the Revita group maintains well.

$GUTS all looks good but I did sell 25% of my position today, purely for risk control. I now own a still-beefy amount at about a $0.15 basis, and will keep that through FDA catalysts / approval. For those who are technical traders - yes, there is some resistance to be expected between $0.90-$1. But on approval, which IMHO is about a 75% probability - we should be seeing $3-$5+ (depending on type & amount of dilution before then).

@VIPSheffTrades Amen, brother!

@VIPSheffTrades I hope it comes out ok, in the end. 😂 🙏

@VIPSheffTrades $OSTX still?

@VIPSheffTrades Love it, ive taken up camping with the family the past couple years and it’s great. Live it up!

@VIPSheffTrades @LovejoyVapor Love your enthusiasm, man 👊as well as your passion and insight. I also greatly appreciate the time you must spend on research. 🏃

@VIPSheffTrades I’ve only missed 1 webinar out of all of them, and today’s was the most enthusiastic EVER! 👊🏻

@VIPSheffTrades Thanks my man, I’ve reduced my position by about 50% over past few days and plan to hold the rest through decision.